boat club sailing in, page-5

tonga

it would be good if you could post something like that on the boat club FB site.

Nick has made all kinds of warnings about the risks that biotechs have.

ADO is not a biotech and it is important to understand why.

This is a mature company with proven science which doesn't have to go through the expense and delay of FDA trials. It is exactly that which usually kills off otherwise promising bios. The marketing stage is also expensive but a strategy is in place for that and things are rolling.

Customisation is also a key cost to ADO but nothing like FDA trials, and it is done collaboratively moving to a user pays system.

As it stands Nick is saying the report is a bit ordinary and unintentionally condemning ADO with faint praise as a biotech. A bit of buzz which will go nowhere IMO unless this is followed up.

DV